SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-025779
Filing Date
2011-05-04
Accepted
2011-05-04 16:37:44
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a11-8529_110q.htm 10-Q 932234
2 EX-10.4 a11-8529_1ex10d4.htm EX-10.4 142849
3 EX-10.48 a11-8529_1ex10d48.htm EX-10.48 64932
4 EX-10.49 a11-8529_1ex10d49.htm EX-10.49 57727
5 EX-10.50 a11-8529_1ex10d50.htm EX-10.50 46003
6 EX-10.51 a11-8529_1ex10d51.htm EX-10.51 66476
7 EX-10.52 a11-8529_1ex10d52.htm EX-10.52 92558
8 EX-10.53 a11-8529_1ex10d53.htm EX-10.53 126218
9 EX-31.1 a11-8529_1ex31d1.htm EX-31.1 12987
10 EX-31.2 a11-8529_1ex31d2.htm EX-31.2 13730
11 EX-32 a11-8529_1ex32.htm EX-32 11464
  Complete submission text file 0001104659-11-025779.txt   1568251
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 11810878
SIC: 2834 Pharmaceutical Preparations